RecruitingNCT07137468

Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk

Excessive Weight, Breast Cancer, and Endocrine Disrupting Chemicals (EDCs): Findings From Active Living After Cancer (ALAC) With Environmental Vitality

Sponsor

M.D. Anderson Cancer Center

Enrollment

30 participants

Start Date

Jan 6, 2026

Study Type

OBSERVATIONAL

Conditions

Breast Cancer

Summary

To learn about breast cancer survivors' and their family members' knowledge of and interest in learning about environmental exposures related to personal care products. Researchers also want to learn if there is a link between excessive weight and chemicals that may affect hormones.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how everyday chemical exposures (such as from personal care products or household items) and body weight may affect breast cancer risk and outcomes. Researchers will interview breast cancer survivors from the Acres Home community in Houston to collect information about their exposures and experiences. **You may be eligible if...** - You live in the Acres Home community - You are 18 years or older - You have been diagnosed with breast cancer (any subtype) - You are a current or former participant in the ALAC (Acres Linking and Advocating for Community) program - You can communicate in English **You may NOT be eligible if...** - You have been diagnosed with metastatic breast cancer (cancer that has spread to distant organs) - You are unable to communicate in English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSurveys

Electronic surveys will completed via REDCap.

OTHERVideo

Focus group sessions and community forums will be conducted via videoconference (Zoom)

Locations(1)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07137468

Related Trials

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

NCT072011941 location

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT066782697 locations

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

NCT0587057925 locations

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

NCT0624799533 locations

Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

NCT049211378 locations